Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Myeloma Knowledge Exchange 2019 (MyKE Myeloma) /
Filtering through the options: Renal considerations in disease management

10th - 11th May 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 14.05.19
Views: 1149

Prof Paul Cockwell - University Hospitals Birmingham, Birmingham, UK

Prof Paul Cockwell speaks to ecancer at the 2019 MyKE Myeloma meeting in Barcelona about the renal complications associated with multiple myeloma.

He describes how these patients are currently managed - in which high-quality supportive care is essential, along with an accurate and prompt diagnosis.

Prof Cockwell also explains the relationship between renal recovery and the clinical outcomes of these patients, where patients with recovered kidney function experience better long-term outcomes.

He also believes the immediate and accurate detection of kidney function changes combined with the most suitable chemotherapy regimen, will help manage these patients more effectively in the future.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation